Riskpilot← Back to searchSign inGet full accessRewell Medical AB
ABActiveOrg 5591552392Kölnagatan 4Other software publishing · NACE 5829Est. 20181-4 employees
Revenue 2024
SEK 372K
EBITDA margin
-2625.5%
-71% vs 2023
Equity ratio
61.8%
Financial strength
Net profit 2024
SEK -7,3M
+34% vs 2023
| Revenue | SEK 372K | — |
| EBITDA | SEK -9,8M | -71% |
| Net profit | SEK -7,3M | +34% |
| Total assets | SEK 43,7M | +2% |
| Equity | SEK 27M | -21% |
| Employees | — | — |
Legal name
Rewell Medical AB
Org number
5591552392
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
10 april 2018
Share capital
SEK 679 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska äga och förvalta immateriella rättigheter samt arbeta med dataprogrammering av tekniska plattformar och andra tekniska lösningar, som erbjuds kunder via licensiering och andra intäktsmodeller. Bolaget ska också bedriva konsultverksamhet med inriktning på verksamhetsutveckling, digitala processer, ledningsrådgivning samt äga och förvalta aktier i andra bolag samt därmed förenlig verksamhet.
Address
Kölnagatan 4
Email
par.svensson@rewell.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 186 | 8 | 480 | 0 | 372 |
| Staff expenses | — | — | — | — | −7 500 |
| EBITDA | −7 182 | −7 078 | −5 374 | −5 699 | −9 767 |
| Depreciation & amort. | −1 474 | −2 579 | −1 110 | −1 110 | −1 110 |
| EBIT | −8 656 | −9 657 | −6 484 | −6 809 | −9 939 |
| Net financials | −47 | −4 826 | −6 368 | −4 183 | −507 |
| Profit before tax | −10 126 | −14 130 | −12 852 | −10 992 | −5 587 |
| Tax | 2 014 | 1 690 | 1 136 | −38 | −1 739 |
| Net profit | −8 112 | −12 440 | −11 716 | −11 030 | −7 326 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 317 | 45 759 | 45 736 | 42 722 | 43 654 |
| Equity | 22 784 | 43 633 | 42 326 | 34 302 | 26 976 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 445 | 3 392 | 3 409 | 8 420 | 16 678 |
| Total debt | 1 445 | 3 392 | 3 409 | 8 420 | 16 678 |
EBITDA margin
-2625.5%
This company
15.8%
Market median
-16717% vs market
20202024
Equity ratio
61.8%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
-27.2%
This company
18.4%
Market median
-248% vs market
20202024
Net profit margin
-1969.4%
This company
8.1%
Market median
-24414% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PK Chief Executive Officer | Chief Executive Officer | 2024 |
HP | Audit | 2021 |
| Former (3) | ||
PA Audit | Audit | 2022 – 2023 |
KJ Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
JK Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2024 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rewell Medical AB 
Ekenhälsan Rewell ABBoard members of Rewell Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Anders Fridolin | Audit | 0 companies |
| Pär Karl Axel Svensson | Chief Executive Officer | 0 companies |
| Karl Jonas Thörnholm | Chief Executive Officer | 0 companies |
| Jan Krister Nilsson | Chief Executive Officer | 0 companies |
| Hans Peter Gustafsson | Audit | 0 companies |
| Jasinta Cecilia Rajan | Deputy Board Member | 0 companies |
| Georg Tsaros | Chairman | 0 companies |
| Tord Stefan Erik Arver | Board of Directors | 0 companies |
| Filip Weintraub | Board of Directors | 0 companies |
| Per Fredrik Bexelius | Board of Directors | 0 companies |
| Anders Harald Milton | Chairman | 0 companies |